ArticleFrontiers in pharmacology2023

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors.

Lukas Fiedler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.